Relmada Therapeutics Inc. sell Lokrim
Start price
19.08.24
/
20%
€2.48
Target price
19.08.25
-
Performance (%)
-79.23%
End price
20.08.25
€0.52
Summary
This prediction ended on 20.08.25 with a price of €0.52. Lokrim correctly predicted massive losses of -79.23% for Relmada Therapeutics Inc.. Lokrim has 20% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Relmada Therapeutics Inc. | - | - | - |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% |
According to Lokrim what are the pros and cons of Relmada Therapeutics Inc. for the foreseeable future?
Pros
Cons
Probably not worthwhile Investment
Revenue decline/stagnation expected
Comments by Lokrim for this prediction
In the thread Relmada Therapeutics Inc. diskutieren
Sell Relmada Therapeutics Inc.
In the thread Trading Relmada Therapeutics Inc.
Die von Lokrim gewählte maximale Laufzeit wurde überschritten